Download PDF
Am J Perinatol 2001; 18(2): 113-116
DOI: 10.1055/s-2001-13637
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Transient Fetal Hypothyroidism Due to Direct Fetal Administration of Amiodarone for Drug Resistant Fetal Tachycardia

Jesse Vanbesien, Ann Casteels, Adel Bougatef, Luc De Catte, Walter Foulon, Sonja De Bock, Johan Smitz, Jean De Schepper
  • Academisch Ziekenhuis Kinderen, Vrije Universiteit Brussel, Brussels-Jette, Belgium
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Amiodarone, an anti-arrhythmic drug that contains 39% iodine, is rarely known to cause negative effects on fetal thyroid function after gestational exposure, when given orally to a pregnant woman. Two cases of fetal hypothyroidism after gestational exposure to amiodarone by direct fetal intravenous route are described here.

KEYWORD

Iodine - prematurity - thyroxine

REFERENCES

  • 1 De Catte L, De Wolf D, Smitz J, Bougatef A, De Schepper J, Foulon W. Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia.  Prenat Diagn . 1994;  14 762-765
    PubMedSearch in Google Scholar
  • 2 Mason J W. Amiodarone.  N Engl J Med . 1987;  316 455-466
    PubMedSearch in Google Scholar
  • 3 Plomp T A, Vulsma T, de Vijlder J M J. Use of amiodarone during pregnancy.  Eur J Obstet Gynecol Reprod Biol . 1992;  43 201-207
    PubMedSearch in Google Scholar
  • 4 Harjai K J, Licata A A. Effects of amiodarone on thyroid function.  Ann Intern Med . 1997;  126 63-73
    CrossrefPubMedSearch in Google Scholar
  • 5 Valenisise H, Civitella C, Garzetti G G, Romanini C. Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.  Prenat Diagn . 1992;  12 705-708
    PubMedSearch in Google Scholar
  • 6 Trip M D, Wiersinga W, Plomp T A. Incidence, predictability and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism.  Am J Med . 1991;  91 507-511
    CrossrefPubMedSearch in Google Scholar
  • 7 De Wolf D, De Schepper J, Verhaaren H, Deneyer M, Smitz J, Sacre-Smits L. Congenital hypothyroid goiter and amiodarone.  Acta Paediatr Scand . 1988;  77 616-618
    PubMedSearch in Google Scholar
  • 8 Matsumura L K, Born D, Kunii I S, Franco D B, Maciel R MB. Outcome of thyroid function in newborns from mothers treated with amiodarone.  Thyroid . 1992;  2 279-281
    PubMedSearch in Google Scholar
  • 9 Darwiche A, Vanliefeinghen P, Lemery D, Paire M, Lusson J R. Amiodarone et tachycardie supraventriculaire foetale: a propos d'un cas avec hypothyroidie néonatale.  Arch Fr Pediatr . 1992;  49 729-731
    PubMedSearch in Google Scholar
  • 10 Grosso D, Berarde R, Cioni M, Morgese G. Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases.  J Endocrinol Invest . 1998;  21 699-702
    PubMedSearch in Google Scholar
  • 11 Magee L A, Downar E, Sermer M, Boulton B C, Allen L C, Koren G. Pregnancy outcome after gestational exposure to amiodarone in Canada.  Am J Obstet Gynecol . 1995;  172 1307-1311
    CrossrefPubMedSearch in Google Scholar
  • 12 Noia G, De Santis M, Tocci A. Early prenatal diagnosis and therapy of fetal hypothyroid goiter.  Fetal Diagn Ther . 1992;  7 138-143
    PubMedSearch in Google Scholar
  • 13 Fisher D A, Klein A H. Thyroid development and disorders of thyroid function in the newborn.  N Engl J Med . 1981;  304 702-712
    PubMedSearch in Google Scholar